Chlorogenic Acid

DB12029InvestigationalSmall molecule

Chlorogenic Acid has been used in trials studying the treatment of Advanced Cancer and Impaired Glucose Tolerance.

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor M3, Acetylcholinesterase, and Aldo-keto reductase family 1 member B1
Curator reviewed
Formula / weight: C₁₆H₁₈O₉ · 354.3087 g/mol (avg)
Code names: NSC-407296 · NSC-70861

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyCWVRJTMFETXNAD-JUHZACGLSA-NSMILESO[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@@H]1O)C(O)=O

Targets

What you can answer from here — as of July 07, 2026

8Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Chlorogenic Acid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.